RE:RE:RE:RE:Trial ResultsI woud also expect a follow-up to this soon. This news release doesn't talk about WHAT, specifically, their roadmap is for this successful formulation, or if they are just going to sit on it until they can produce it themselves. It just talks about a new trial for felines. I was half expecting an announcement like this to include an application filing announcement with HC. Was a bit surprised by that actually, especially with these positive results.
I know this is a highly competitive space right now, several companies have launched into trials like this. So I expect there is some strategy here to determine their next move carefully, or maybe they file quietly and announce when they get something back from HC.
I feel this news release is just a piece of what is really going on here. Would love to chat with Feldman about this later this week.
TenFingers wrote: If I've learned anything about the patterns of news releases for LIB, it's that they love to fire in waves. :) It wouldn't surprise me to see this tomorrow, or this week for sure.
And what about Signature? That is a wildcard right now that I'm loving.
Ovechkin wrote: Thanks buddy. AOR for JK next
TenFingers wrote: Also congrats to the LIB team for delivering on time and as expected.
8 months from december 20th - to the DAY. Ovy called it.
TenFingers wrote: This study meets the HC requirements (16 subjects and other parameters). As far as I can tell, they can immediately apply for a license on this formula as they proceed to secure further formulations to treat other conditions and expand to feline studies.
This is a big card for them. 15 out of 16 subjects benefitted. We are rounding a corner where pet owners are not going to want to purchase rogue products to treat their fur babies. They want a sanctioned formula. LIB will have it.